权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Clinical Research Resources and Facilities Core

临床研究资源和设施核心

基本信息

批准号：
10260525
负责人：
MARC D. BASSON
金额：
$ 32.47万
依托单位：
UNIVERSITY OF NORTH DAKOTA
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-01 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10260525
关键词：
Address Affect Archives Biological Biometry Blood Body Fluids Cancer Prognosis Clinical Clinical Data Clinical Research Clinical Services Clinical Trials Collaborations Communities Complement Computerized Medical Record Consultations Core Facility Data Set Databases Deposition Development Environment Equipment and supply inventories Fostering Goals Grant Health Hospitals Individual Infrastructure Institutes Letters Link Location Malignant Neoplasms Methodology Mission Nature North Dakota Patient Recruitments Patients Pharmaceutical Preparations Population Population Heterogeneity Preparation Procedures Protocols documentation Research Research Design Research Infrastructure Research Personnel Research Project Grants Resource Sharing Resources Rural Community Sampling Services Site South Dakota Students System Technology Time Study Tissue Sample Translational Research Underserved Population Work biobank cancer biomarkers cancer care cancer health disparity cancer therapy cancer type care delivery competitive environment cost epidemiology study innovation investigator training neoplasm registry novel personalized genomic medicine research facility rural underserved sample collection synergism translational cancer research tribal community tumor progression

项目摘要

DACCOTA-Clinical Research Resources and Facilities Core Summary: The overall goal of the Clinical Research Resources and Facilities Core is to provide synergy and expansion opportunities to the existing clinical services and technology cores available through partnering institutes, thereby fostering an ideal environment for the competitive execution of clinical and translational cancer research. This core will facilitate access to essential services necessary for establishing, executing, and communicating clinical and translational cancer research to allow for the seamless progression from ideas to results. The goal of this core is to promote CTR by expanding the biorepository of biological samples essential for advancing genomic/personalized medicine and translational research. Researchers will use these biobank samples to identify biomarkers for cancer progression and prognosis and/or determine medication tolerance. The DACCOTA will utilize an established biorepository with state-of-the-art technology to handle and inventory all samples, while also linking patient samples to the electronic medical records. The goal of this core is to share resources, develop new protocols for treating patients, and assist with various clinical trials as we move forward with our mission to increase clinical and translational cancer research.

DACCOTA-Clinical Research Resources and Facilities Core Summary: The overall goal of the Clinical Research Resources and Facilities Core is to provide synergy and expansion opportunities to the existing clinical services and technology cores available through partnering institutes, thereby fostering an ideal environment for the competitive execution of clinical and translational cancer research. This core will facilitate access to essential services necessary for establishing, executing, and communicating clinical and translational cancer research to allow for the seamless progression from ideas to results.该核心的目标是 promote CTR by expanding the biorepository of biological samples essential for advancing genomic/personalized medicine and translational research. Researchers will use these biobank samples to identify biomarkers for cancer progression and prognosis and/or determine medication 宽容。 The DACCOTA will utilize an established biorepository with state-of-the-art technology to handle and inventory all samples, while also linking patient samples to the electronic medical 记录。 The goal of this core is to share resources, develop new protocols for treating patients, and assist with various clinical trials as we move forward with our mission to increase clinical and translational cancer research.